WHO ICTRP trial
A Modular, Multipart, Multi-arm, Open-label, Phase I/IIa Study to Evaluate the…
NL-OMON52508 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting
Key facts
| Trial ID | NL-OMON52508 |
|---|---|
| Public title | A Modular, Multipart, Multi-arm, Open-label, Phase I/IIa Study to Evaluate the Safety and Tolerability of EP0042 Alone and in Combination with Anti-cancer Treatments in Patients with Advanced Malignancies |
| Scientific title | A Modular, Multipart, Multi-arm, Open-label, Phase I/IIa Study to Evaluate the Safety and Tolerability of EP0042 Alone and in Combination with Anti-cancer Treatments in Patients with Advanced Malignancies - EP0042-101 |
| Primary sponsor | Ellipses Pharma Limited |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Countries | Australia;Netherlands;United Kingdom;United States of America |
| Conditions | Cancer Malignancy;10024324 |
| Interventions | This is a modular, Phase I/IIa study to investigate the optimal dose of EP0042 when used as monotherapy dose or in combination with other anti-cancer treatments. The design consists of a core study protocol and individual modules, as… |
| Registration date | Mar 19, 2021 |
| Target size | 13 |
| Secondary IDs | 2020-000168-53;NCT04581512;NL74204.078.20 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: